Professional Documents
Culture Documents
)
Lead Molecules from Natural Products
r 2006 Published by Elsevier B.V.
111
Phytotherapy of cough
Abstract
The problems emerging from the treatment of cough during many types of respiratory diseases by con-
ventional opioid antitussive agents, such as codeine and codeine-like compounds, are well known. In
recent years, much effort has been made to create drugs that exhibit minimum side effect on the organism.
One of them is the medicinal plants, which are potential source of substances with high-antitussive
efficiency with minimal unwanted effects. Recent trends of modern phytotherapy include specification of
active substances responsible for therapeutic effect as well as their quantification in the healing drugs,
which enables the treatment rationalization, especially the dosing and pursuing of adverse effects. The
purpose of this chapter is to give the overview of some medicinal plants and their active compounds with
cough-suppressing activity. The common information about antitussive efficiency of selected herbal
products are replenished with results of our ongoing research program related to search for potentially
antitussive active herbal polysaccharides.
I. Introduction
Phytotherapy has a very long tradition in the treatment of respiratory-tract diseases.
In time, when medicine had no reliable diagnostic instruments, the diagnostics as
well as therapy were based on symptoms, of which cough was one of the most
important. A large number of herbal preparations is empirically used in the therapy
of cough. Recent trends of modern phytotherapy include specification of active
substances responsible for therapeutic effect as well as their quantification in the
healing drugs, which enables the treatment rationalization, especially the dosing and
pursuing of adverse effects. A permanent hunt for new antitussives from the plant
kingdom has its substantiation related to adverse effects of opioid antitussives. The
administration of these centrally acting cough-suppressing agents has its importance
in some indications, associated especially with painful cough. But during long-lasting
applications, the risk of dependence is rising as well as increasing phlegm viscosity,
depression of the cough center, and other adverse effects.
The basic mechanism of action of herbal antitussives may be the same as those
of orthodox antitussives, most of which originate from herbal predecessors. The
112 Lead molecules from natural products: discovery and new trends
In common inflammations of the airways associated with the cough, the admini-
stration of herbal products is very beneficial, as they can stimulate expectoration via
higher production and expulsion of phlegm with protective effect on the airway
mucous membrane and they can also correct the phlegm properties.
The plant expectorants can act in the following ways:
The following active substances are responsible for antitussive and expectorant
effect in herbal medicinal products.
Saponins. The mechanism of action of saponins belongs to the best-clarified
mechanisms of substances from herbal drugs, which can modulate the cough
parameters and phlegm quality. Saponins are heterosides and are made of glycid and
non-glycid parts. The non-glycid part, the so-called aglycone, is responsible for its
pharmacological effects. After peroral administration of therapeutic doses, the sap-
onins irritate vagal nerves reflexively (Baltina, 2003). This leads to increased phlegm
secretion in the airways (Korpas and Nosalova, 1991). Additionally, the breathing
and the cough center are irritated, resulting in more frequent expectoration. How-
ever, higher doses of saponins can irritate the mucous membrane of stomach and
intestine leading to emesis, diarrhea, and bleeding.
The best-known drugs containing saponins are represented by Radix primulae,
Herba thymi, R. saponariae, and Folium Hederae helicis.
The administration of H. helix leaves extract confirmed under clinical conditions,
using double-blind trial, the ability to suppress the cough reflex in patients with
chronic bronchitis. The antitussive activity of F. H. helicis extract was comparable to
cough-suppressive activity of ambroxol (Meyer-Wegener et al., 1993). It is based
both on high content of saponins and on flavonoids or tannins presence, respectively.
Phytotherapy of cough 113
The single active polysaccharides are probably responsible for antitussive activity
of slime. The polysaccharides showed significant cough-suppressive effects under
experimental conditions, overlapping the effects of peripherally acting antitussives
(Table 1).
Except for significant antitussive activity, glucuronoxylans from herb of
Rudbeckia fulgida and stem of Mahonia aquifolium showed in experimental condi-
tions are immunomodulating activity on innate cellular and humoral immunity
(Bukovsky et al., 1998; Kostalova et al., 2001; Ebringerova et al., 2002).
So far no significant adverse effects were observed after administration of slime
drugs.
Gums. Gums are natural plant hydrocolloids, translucent, amorphous substances
that are frequently produced in higher plants as a protective after injury. An effort
has been made to distinguish between mucilage and gums on the basis that gums
readily dissolve in water, whereas mucilages form slimy masses. Gums are typically
heterogeneous in composition. Upon hydrolysis, arabinose, galactose, glucose, man-
nose, xylose, and various uronic acids are the most frequently observed components
(Tyler et al., 1988). The herbal gums have significant antitussive effect after peroral
administration. Krajkovicova et al. (2002) followed the antitussive effect of gum
isolated from peach. The results showed that this substance had in dose of 50 mg/kg
body wt. higher antitussive effect (38.2%) when was compared to efficacy of
peripherally acting antitusives dropropizine (27.4%) and prenoxdiazine (23.7%).
The mechanism of cough-suppressing action is probably the same as for mucilage.
Pectins. Pectin is a purified carbohydrate product obtained from the dilute
acid extract of the inner portion of the rind of citrus fruit or from the apple pomace.
It is a natural hydrophilic colloid, consisting chiefly of partially methoxylated
polygalacturonic acids; the main carbohydrate component is linear, 1-4-linked
Table 1
Comparison of the antitussive activity of the mixtures of polysaccharides and rhamnoga-
lacturonans from medicinal plants with clinically used antitussives codeine, prenoxdiazine,
and dropropizine
6
number of cough efforts
Control 0.5 1 2 5 hr
9
8
7
6
5
4
3
2
Control 0.5 1 2 5 hr
Fig. 1. Number of cough efforts after administration of S. althaeae (Sir. alth. – dose 1 g/kg
b.w.), water root extract of A. officinalis (extract – dose 100 mg/kg b.w.), mucilage (dose
100 mg/kg b.w.), and rhamnogalacturonan (rhamno – dose 50 mg/kg b.w.).Symbols represent
the average values; the range represents the standard error of means (7SEM).
from clinical point of view, because they indicate that the tested compound sup-
pressed the cough reflex, but promote the expectoration.
The antitussive activity of single components of A. officinalis was compared to
antitussive activity of antitussives usually prescribed in clinical practice (Figure 2).
According to these results, the cough-suppressing effect of mucilage from S. althaeae,
was comparable to the activity of peripherally active antitussive dropropizine. The
administration of rhamnogalacturonan was associated with significantly higher an-
titussive activity compared to slime, S. althaeae and peripheral antitussives, although
it did not reach the effect of opioid antitussive codeine (Nosalova et al., 1993).
Phytotherapy of cough 117
Sir. Alth
Mucilage
Rhamno
Codeine
Dropro
0 10 20 30 40 50 60 70
Fig. 2. Comparison of antitussive activity of S. althaeae (Sir. alth. – dose 1 g/kg b.w.), mu-
cilage (dose 100 mg/kg), rhamnogalacturonan (rhamno – dose 50 mg/kg b.w.) with codeine
(codeine – dose 10 mg/kg b.w.), and dropropizine (dropro – dose 100 /mg kg b.w.) on the
mechanically induced cough reflex under experimental conditions.
Side effects and interactions. So far there were no significantly adverse effects
observed after the administration of products from marshmallow root. Therefore,
their use is recommended in pediatric practice.
Marshmallow mucilage can interfere with the absorption of other medicines
within the digestive tract if they are taken at the same time. One has to take pre-
scriped medications to consuming marshmallow tea at an alternating time.
Therapeutic use. Extracts of leaves and fruits of E. officinalis are used in Indian
traditional system of medicine, Ayurveda, for antiinflammatory, antipyretic prop-
erties or in the treatment of pancreatic disorders for their spasmolytic activities.
Other effects of this plant, such as action against free radicals, damage induced
during stress, protective effects against chemical carcinogenesis, protection against
genotoxicity induced by aluminum, lead, nickel chloride better than ascorbic acid,
have all been reported (Dhir et al., 1993). Among other effects are the inhibition
of lipid peroxidation, antibacterial effects, antiatherosclerotic, and hypolipidemic
activity. The water fraction of methanol extract inhibited migration of human
polymorphonuclear cells and platelets at relatively low concentration (Ihantola-
Vormisto et al., 1997).
Ethanol extracts of fruits of E. officinalis exhibit significant antitussive activity.
The antitussive activity of this fruit extract was tested in conscious cats by mechani-
cal stimulation of the laryngopharyngeal and tracheobronchial mucous areas of the
airways (Nosalova et al., 2003). The results showed that the peroral dose (200 mg/kg
b.w.) of this substance was effective in decreasing the cough parameters. The cough-
suppressing activity of E. officinalis was lower than that of centrally acting codeine,
but higher than the antitussive activity of the commonly used non-opioid antitussives
dropropizine and prenoxdiazine (Figure 3). It is supposed that this activity of extract
of E. officinalis is related to inhibition of prostaglandin and leukotriene synthesis.
Some experimental data suggest that the plant contains as yet unidentified polar
compounds, which inhibit both prostanoid and leukotriene synthesis. Among phar-
macological properties, which could play a role in the antitussive efficacy of this
plant extract, antioxidant, spasmolytic, and antibacterial properties are the chief
80
60
antitussive activity (%)
40
20
0
Codeine Dropro Prenox Emblica
Fig. 3. Comparison of antitussive activity of E. officinalis (Emblica – dose 200 mg/kg b.w.),
codeine (dose 10 mg/kg b.w.), dropropizine (dropro – dose 100 mg/kg b.w.), and prenoxdiazine
(prenox – dose 30 mg/kg b.w.) on the mechanically induced cough reflex under experimental
conditions.
Phytotherapy of cough 119
ones. The extract of E. officinalis probably has an irritant effect on the neural vagal
endings of the gastrointestinal mucous membranes, which also stimulates the secre-
tion of mucus in the respiratory tract. Therefore, the airways are covered with mucus
and the cough receptors are hardly accessible for irritation, leading to a decrease in
the cough reflex.
Side effects and contraindication. An increased salivation and diuresis was ob-
served after the administration of E. officinalis preparations. Overdose of therapeutic
range can lead to emesis (Achliya et al., 2004).
Therapeutic use. The therapeutic effects of the drug are associated with high con-
tent of the slime. The experimental studies on mucous membranes showed that slime
sticks to the mucous membrane in water solution and protects it from irritation.
Therefore, the mallow is prescribed especially in painful inflammations of oral
cavity, pharynx, and upper airways. It was proved particularly in inflammation
without expectoration and in non-productive cough.
The antitussive activity of the slime from M. mauritiana L. flowers is mediated
probably by acid polysaccharide rhamnogalacturonan, separated via gel chromatog-
raphy on DEAE-Sephadex A-50. Its major sugar components are L-rhamnose,
D-galacturonic acid, and D-galactose. The results of antitussive activity tests per-
formed with the mucilage, and acid polysaccharide component (rhamnogalactu-
ronan), showed that both compounds suppressed the cough reflex, which was induced
under experimental conditions. However, the administration of rhamnogalacturonan
at a dose of 50 mg/kg b.w. was associated with 15% higher antitussive activity com-
pared to the slime (Nosalova et al., 1994). Mucilage and rhamnogalacturonan caused
statistically significant decrease in cough parameters mainly from laryngopharyngeal
area of the airways. This indicates a dominant peripheral mechanism of action, when
compared to the centrally active codeine, which suppressed the more expressive cough
reflex from tracheobronchial region.
The ability of mucilage and rhamnogalacturonan to suppress the cough parameters
was compared to those of drugs commonly used in clinical practice. The activity,
both of mucilage and its rhamnogalacturonan, was lower than that of codeine, but
higher than that of peripherally acting antitussives, dropropizine and prenoxdiazine
(Table 2).
Side effects and contraindications. So far no significant adverse effects associated
with administration of M. sylvestris or M. mauritiana products were observed. Simi-
larly as by other plants containing the slime, their administration may result in
lower resorption of some medicines from stomach. Therefore, the administration
of other drugs approximately 1 h before the use of mallow plant preparations is
recommended.
Table 2
Comparison of the antitussive activity of mucilage and rhamnogalacturonan from the flowers
of M. mauritiana with clinically used antitussives codeine, prenoxdiazine, and dropropizine
of urinary concrements, and decrease the sugar level in organism. The tannins help
by healing the mucous membranes during inflammatory diseases of digestive tract,
and their hydrolysates (D-catechine) decrease the permeability of capillaries. The
agents with similar activity like coumarine derivatives participate in reduction of
platelet activity. Under experimental conditions, it was shown that this effect is
associated with the inhibition of prostaglandin activity and the activity of platelet-
activating factor (PAF) (Tunon et al., 1995). A well-known fact is also that these
mediators play an important role in inflammatory diseases of the airways and their
inhibition can participate in antiinflammatory effect of knotgrass in this system.
Contraindications and side effects. After administration of knotgrass preparations,
there were no adverse effects so far. Higher doses can have pro-diuretic effect.
Consulting a specialist is recommended before prescribing the drug to patients with
diseases associated with platelet dysfunction.
Contraindications and side effects. Several-folds higher dose has toxic effects.
Overdosage of Primula may cause stomach upset, nausea, and diarrhea. Skin re-
action may occur for those allergic to Primula. The roots are not to be taken with
aspirin, as they are rich in salicylates (Gajdos et al., 1996).
contributes to its expectorant effect. The slime makes a protective layer on the
airway mucous membrane, and this leads to decreased irritation of cough receptors
by inflammation mediators during inflammation (Blumenthal et al., 2000). The
mullein drug is usually combined with other expectorant and mucilageous drugs
containing essences and slime, such as F. anisi, F. foeniculi, H. menthae piperitae,
H. thymi, F. malvae sylvestris, F. althaeae, and F. plantaginis.
In addition to having an influence on respiratory system, the agents from slime can
act as protective agents during inflammation of esophagus, and, in smaller extent,
stomach and intestine. Infusion of F. verbasci has antiviral activity against influenza
and Herpes simplex viruses (Zgorniak-Nowosielska et al., 1991). The drug is pre-
scribed as adjuvant by dyspepsia with diarrhoe, where action of tannin is suggested.
Contraindications and side effects. The contraindications and side effects are not
known. The leaf hairs of mullein species can cause skin irritation in susceptible
persons (Romaguera et al., 1985).
References
Achliya GS, Wadodkar SG, Avinash KD. (2004) Neuropharmacological actions of an-
chagavya formulation containing Emblica officinalis Gaerth and Glycyrrhiza glabra Linn in
mice. Indian J Exp Biol 42:499–503.
Alzoreky NS, Nakahara K. (2003) Antibacterial activity of extracts from some edible plants
commonly consumed in Asia. Int J Food Microbiol 80:223–30.
Asmawi MZ, Kankaanranta H, Moilanen E, Vapaatalo H. (1993) Anti-inflammatory activi-
ties of Emblica officinalis Gaerth. Leaf extracts. J Pharmacol 45(6):581–4.
Baltina LA. (2003) Chemical modification of glycyrrhizic acid as a route to new bioactive
compounds for medicine. Curr Med Chem 10:155–71.
Blumenthal, M, Goldberg, A, Brinckmann, J. (2000) Herbal medicine: expanded commission
E monographs. American Botanical Council. Newton: Integrative Medicine Communica-
tions. pp. 270–272
Bukovsky M, Kardosova A, Koscova H, Kostalova D. (1998) Immunomodulating activity
of 4-O-Methyl-D-glucurono-D-xylan from Rudbeckia fulgida, var. sullivantii. Biologia,
Bratislava 53:771–5.
Burrow A, Eccles R, Jones AS. (1983) The effects of camphor, eucalyptus and menthol vapour
on nasal resistance to airflow and nasal sensation. Acta Otolaryngol 96(1–2):157–61.
Cantrell CL, Abate L, Fronczek FR, Franzblau SG, Quijano L, Fisher NH. (1999) Anti-
mycobacterial eudesmanolides from Inula helenium and Rudbeckia submentosa. Planta Med
65(4):351–5.
Chang HW, Baek SH, Chung KW, Son KH, Kim HP, Kang SS. (1994) Inactivation of
phospholipase A2 by naturally occuring bioflavonoid, ochnaflone. Biochem Biophys Res
Commun 205:843–9.
Crowell PL. (1999) Prevention and therapy of cancer by dietary monoterpenes. J Nutr
129:775S–8S.
Dhir H, Roy AK, Sharma A. (1993) Relative efficiency of Phyllanthus emblica fruit extract
and ascorbic acid in modifying lead and aluminium-induced sister-chromatid exchanges in
mouse bone marrow. Environ Mol Mutagen 21(3):229–36.
Duke J. (1997a) The Green Pharmacy, the ultimate compendium of natural remedies from the
world’s foremost authority on healing herbs. Rodale Press, pp. 53, 55–56, 146, 290–291,
299–300.
Duke J. (1997b) The Green Pharmacy, the ultimate compendium of natural remedies from the
world’s foremost authority on healing herbs. Rodale Press, pp. 53, 104, 119, 181, 187, 207,
479, 491.
Phytotherapy of cough 129
Tyler VE, Brady LR, Robbers JE. (1988) Pharmacognosy, 9th edition. Philadelphia, PA: Lea
and Febiger, pp. 26–45.
Weiss RF. (1985) Herbal medicine. (Trans. Meuss AR) Gothenburg. Sweden: Ab Arcanum
and Beaconsfield, Bieconsfield Publishers Ltd.
Wichtl M, Bisset NG. (1994) Primula radix – primula root. Herbal drugs and phyto-
pharmaceuticals. Stuttgart: CRC Press, pp. 390–395.
Wichtl M, Bisset NG. (1994) Primula flos – primula flower. Herbal drugs and phyto-
pharmaceuticals. Stuttgart: CRC Press, pp. 388–389.
Wichtl M, Bisset NG. (1994) Foeniculi fructus – fennel. Herbal drugs and phyto-pharma-
ceuticals. Stuttgart: CRC Press, pp. 200–202.
Zgorniak-Nowosielska I, Grzybek J, Manolova N, Serkedjieva J, Zawlinska B. (1991) An-
tiviral activity of flos verbasci infusion against influenza and Herpes simplex viruses. Arch
Immunol Ther Exp 39(1–2):103–8.